Workflow
Test Systems
icon
Search documents
inTEST (INTT) - 2025 Q2 - Earnings Call Transcript
2025-08-06 13:30
Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $28.1 million, with gross margins above 42% [7][13] - Net loss for the quarter was $500,000, or a loss of $0.04 per diluted share, while adjusted net earnings were $400,000, or a gain of $0.03 per diluted share [16] - Adjusted EBITDA for Q2 was $1.3 million [16] - Total debt was approximately $10.1 million at quarter end, reduced by $4.9 million year-to-date [17] Business Line Data and Key Metrics Changes - Orders for the quarter were nearly $28 million, reflecting a 10% sequential growth [10] - Auto EV demand increased by 40% to $7.1 million, while Life Sciences more than doubled to $2.9 million [10] - Safety and Security grew 74% to $1.2 million, but semi orders decreased by 24% sequentially [10] Market Data and Key Metrics Changes - Demand in the auto EV market increased significantly, while the semi market remained weak with a year-over-year decline of $3.7 million [11] - Backlog at June 30 was $37.9 million, flat over the last two quarters but down $9.8 million from the prior year [11] Company Strategy and Development Direction - The company is focused on driving innovation, market diversification, and geographic expansion as part of its Vision 2030 strategy [8][21] - The expansion of the manufacturing facility in Malaysia is expected to enhance market competitiveness and drive growth [9][21] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing global economic and tariff uncertainties affecting customer investment in capital projects [6][21] - The customer pipeline is at an all-time high, indicating optimism for future capital spending [20][21] Other Important Information - The company has implemented cost-saving measures, including headcount reductions and operational restructuring, to improve long-term profitability [15][48] - The Malaysian facility is expected to generate $10 million to $15 million in revenue over time, supporting the Asian market [28][54] Q&A Session Summary Question: Is the recent defense order from a new customer? - The defense order is from an existing customer, following previous deliveries of prototype units [24][25] Question: How have customer order patterns been in the first six weeks of the quarter? - Order patterns have shown improvement, particularly in the automotive industry and defense space [26][27] Question: What is the capacity of the Malaysian facility? - The Malaysian facility is anticipated to support $10 million to $15 million in revenue over time [28] Question: Were the engineering challenges in Q1 related to defense? - The engineering challenges were primarily in industrial applications, not defense [31] Question: What are the expectations for the semi market in 2026? - A rebound in the semi market is expected in 2026, but the timing is still uncertain [33] Question: What is the outlook for life sciences orders? - There is a strong pipeline for continued orders in life sciences, driven by medical device electronics [35] Question: What are the leading indicators for order activity? - New products and a high customer pipeline are seen as positive indicators for future order activity [42][44] Question: How is the company managing operating expenses? - The company has reduced headcount and discretionary spending, with some savings expected to be temporary [46][48] Question: How will the Malaysian operations impact existing facilities? - The Malaysian facility aims to drive growth without significantly shifting operations from the U.S. [52][54]